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Premature mortality, defined here as mortality occurring before the average life expectancy, accounts for 
about 67,000 deaths and more than half the 
all-cause mortality in Australia.1 The value of 
productivity lost due to premature mortality 
has been shown to be a significant factor in 
the assessment of the total costs of illness.2
Historically, the productivity-related costs of 
mortality have been estimated by applying 
average earnings to the period of production 
lost due to premature death. This is typically 
referred to as the human capital approach, 
and has its basis in the cost of illness 
methodology developed by Rice et al in 
1966.3 Calculation of mortality costs considers 
earnings over a lifetime rather than a single 
year since, if an individual had not died, they 
would have continued to be productive for 
a number of years according to their life 
expectancy. 
Recent studies have applied this 
methodology to estimate the productivity 
related costs of mortality on a disease-specific 
basis, including for cancer,4-10 cardiovascular 
disease (CVD)11,12 and diabetes.13,14 Estimates 
of productivity costs produced by these 
studies have ranged from $19,000 per CVD 
death in the European Union,11 to $288,000 
per cancer death in the US.10 However, there 
have been no estimates of productivity 
losses due to premature mortality reported 
in an Australian context. A literature review 
identified just one study that quantified the 
productivity impacts of all-cause mortality 
across all major illness categories using a 
consistent and rigorous methodology.15 
However, the use of the friction cost method 
in this study, where productivity losses 
were valued only up to the point where an 
employee could be replaced,16 meant that 
the estimates it produced were significantly 
less than studies that had applied the human 
capital approach. Given the variation in the 
methods applied and the types of costs 
included in previous studies, it was difficult 
to compare results across countries and 
diseases.17 
Reliable estimates of the relative productivity 
impacts of all-cause premature mortality 
would provide valuable information to 
decision makers allocating scarce resources 
amongst competing priorities. Australia, like 
most developed countries, has an ageing 
population. The proportion of people 
aged 65 and over is expected to more 
than double over the next few decades, 
resulting in economic consequences that 
will pose significant policy challenges. 
Specifically, population ageing is expected 
to slow Australia’s workforce and economic 
growth, at the very time that burgeoning 
demands are placed on Australia’s health 
and aged care systems. The Australian 
Government Productivity Commission’s 
‘Economic Implications of an Ageing Australia’ 
report identified measures to raise labour 
force participation and productivity as a 
key strategy to enhance income growth 
and the capacity to ‘pay’ for the costs of 
ageing.18 Despite this focus, the potential 
for investment in effective health care 
interventions to increase the size of the 
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Abstract
Objective: To estimate the long-term productivity impacts of all-cause premature mortality in 
Australia by age, sex and cause of death.
Methods: Using a human capital approach, a model was developed to estimate both the 
working years and present value of lifetime income (PVLI) lost due to premature deaths 
that occurred in 2003. Outcomes were modelled on individual level data to the year 2030. A 
discount rate of 3% was applied and results are presented in 2015 Australian dollars.
Results: Premature deaths occurring in 2003 accounted for about 284,000 working years lost 
and $13.8 billion in PVLI lost when modelled to 2030. Deaths from cancer and cardiovascular 
disease accounted for more than half the total PVLI impact. Injuries and mental disorders were 
associated with the highest average PVLI loss per death.
Conclusions: The productivity-related impacts of premature mortality are substantial. This 
study provides an assessment of relative impact of these costs across specific age, sex and 
cause of death categories. 
Implications: Policies and interventions that prevent premature mortality would improve 
both health and economic outcomes. An awareness of the productivity costs associated with 
all-cause mortality may assist decision makers in identifying population and disease subgroups 
where cost-effective health care investment can achieve the greatest economic gains to 
society.
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productive workforce is often overlooked 
in both health economic analyses and the 
broader policy making context. 
A recent study by Schofield et al presented 
the results of a microsimulation model 
developed to estimate the productivity 
impacts of chronic disease in older 
Australians.19 The study reported a substantial 
productivity impact, with an estimated 
112,000 lost productive life years caused by 
chronic illness in older workers in Australia 
between 2010 and 2030. The impact of 
this lost labour force participation on GDP 
was estimated to be $37.79 billion in 2010, 
increasing to $63.73 billion in 2030. The use 
of microsimulation methods in this study 
allowed for the calculation of productivity 
costs to be modelled on an individual basis. 
While the human capital approach was 
maintained, this technique represented a key 
advance over previous studies by enabling 
significantly greater variation and complexity 
to be captured. However, the model was 
developed specifically to assess the impact 
of morbidity and thus did not capture the 
impacts of mortality. To date, microsimulation 
methods have not been applied to estimate 
the productivity impacts of mortality in 
Australia or internationally. 
The aim of this paper was to quantify the 
productivity related impacts of all-cause 
premature mortality in Australia by age, sex 
and cause of death. We developed a new 
microsimulation model, LifeLossMOD, to 
estimate the long-term impacts of premature 
deaths that occurred in 2003 in terms of the 
projected working years lost and the present 
value of lifetime income (PVLI) lost out to the 
year 2030. While previous studies4-14 have 
been limited to projecting the productivity 
impacts of mortality based on assumptions 
around average wage rates, labour force 
participation rates and retirement ages, the 
estimates we report account for a number of 
individual factors that may influence these 
variables.
Methods
The productivity impacts of premature 
mortality were estimated using the human 
capital approach, where the impacts were 
assumed to be equal to the expected lifetime 
outcomes that would have been realised had 
the death been avoided. This is the traditional 
method for valuing production losses3 and it 
remains the most widely adopted approach 
in the recent cost of illness literature.4,5,7,8
We developed a new microsimulation model, 
LifeLossMOD, to apply a counterfactual 
life trajectory to each individual that died 
prematurely in 2003. These alternate 
lifespans provided a set of outcomes that 
were assumed to occur under a hypothetical 
scenario whereby an individual’s death in 
2003 was prevented. The process by which 
LifeLossMOD was developed is described 
in detail in Carter et al.20 and is summarised 
below.
Building the microsimulation model: 
LifeLossMOD
LifeLossMOD was developed using two 
component datasets: a mortality dataset 
and the APPSIM microsimulation model. 
The mortality dataset consisted of 129,513 
individual mortality records representing 
all registered Australian deaths in 2003, as 
compiled by the 2003 Australian Burden 
of Disease and Injury study.21 Given the 
average life expectancy of 80.1 for individuals 
born in 2003 (77.8 for men and 82.8 for 
women),22 we excluded all deaths occurring 
in individuals aged 80 and above from the 
analysis. This is consistent with the Australian 
Institute of Health and Welfare definition 
of premature mortality as deaths occurring 
before a selected age cut-off, which may 
be determined or informed by average life 
expectancy.23 A sensitivity analysis using 75 
years as the threshold for premature death 
was conducted to assess the impact of 
uncertainty around this cut-off.
Each mortality record contained variables 
describing the underlying cause of death 
as well as the individual’s age, sex and the 
socioeconomic status of the suburb they 
resided in (as measured by the ABS’s socio-
economic index for areas (SEIFA) quintiles).24 
However, the mortality dataset did not 
have information on the key economic 
outcomes of interest, including labour force 
participation and income. It was therefore 
necessary to assign estimates of additional 
variables onto the original mortality records, 
which was achieved using data from APPSIM.
APPSIM is a dynamic microsimulation model 
of the Australian population developed by 
the National Centre for Social and Economic 
Modelling to evaluate the impact of future 
fiscal and social policies.25 The model 
uses a one percent sample of the 2001 
Australian Census (188,000 records) as its 
base population. Future lifetime outcomes 
for this population are then projected 
using data from large surveys including the 
Household, Income and Labour Dynamics in 
Australia (HILDA),26 the Longitudinal Study of 
Immigrants to Australia,27 as well as official 
demographic data and projections.28 APPSIM 
is also able to simulate changes to the 
population over time, including births, deaths 
and migration, as well as couple formation 
and separation and children leaving home.29 
In order to estimate the potential productivity 
gains forgone due to deaths occurring in 
2003, each individual in the mortality dataset 
was matched with a similar individual existing 
in year 2003 of APPSIM. The resulting set of 
outcomes projected by APPSIM to the year 
2030 were assumed to represent a series 
of counterfactual life trajectories for each 
individual that died in 2003. This process 
consisted of two steps. First, records in both 
the 2003 mortality dataset and the 2003 
APPSIM population were grouped into 
homogenous cells, or ‘bins’, based on their 
combination of age, sex and SEIFA quintile. In 
the second step, each mortality record within 
a particular bin was matched at random with 
an individual from the APPSIM dataset that 
appeared in the same bin.
To allow for the effects of uncertainty in the 
pairing of records, the matching process 
was replicated 100 times to create 100 
uniquely matched datasets. These 100 
simulated datasets comprise LifeLossMOD. 
The results contained throughout this paper 
report the mean of the 100 datasets. Where 
present, 95% confidence intervals have been 
calculated using the percentile method. 
Estimating the economic impacts of 
premature mortality in 2003
The expected labour force participation lost 
due to premature mortality was estimated by 
accumulating the number of hours worked 
per week between 2003 and 2030 for each 
individual in LifeLossMOD. The impacts 
of mortality on labour force participation 
across individuals working both full-time and 
part-time were generalised using a full-time 
equivalent working year metric. This was 
derived by dividing the accumulated number 
of hours worked by the number of hours in 
a standard Australian working year (1,976, or 
38 hours per week for 52 weeks per year: Fair 
Work Act (Cth) Section 62). 
In order to quantify the productivity loss due 
to premature mortality, an estimate of the 
Present Value of Lifetime Income (PVLI) was 
derived. The PVLI represents the potential 
private income forgone due to premature 
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mortality in 2003, and was calculated as the 
accumulated annual incomes for the period 
between 2003 and 2030 for each individual 
that died in 2003. 
Income was based on the median income 
of the APPSIM working population by age 
and sex in 2003, and included earnings 
from wages and salaries as well as income 
generated from other sources including 
business profits and investments. Transfer 
payments were excluded to avoid double-
counting on a macroeconomic level. The 
modelled income was estimated on an 
annual basis for each individual in the 
mortality cohort, taking into account a 
range of demographic factors including the 
individual’s age, sex, labour force participation 
and life expectancy. Total income was 
assumed to grow at a rate of 1% per annum 
above inflation to reflect economic growth 
projections30,31 and a discount rate of 3% 
was applied. The resulting incomes derived 
from APPSIM were based on 2010 Australian 
dollars (AUD); these figures were inflated to 
AUD 2015 using the national Consumer Price 
Index.31 
Results
Table 1 provides a summary of the total 
number of premature deaths in 2003 by age 
and sex, as well as the counterfactual years of 
life lost (YLL) between 2003 and 2030. Male 
deaths accounted for 62% of all deaths and 
60% of the YLL. Deaths in the 64-80 year age 
category accounted for 61% of the premature 
mortality and 51% of the YLL.
The labour force analysis revealed that a total 
of 284,000 working years were lost due to 
premature deaths occurring in 2003. Male 
deaths were responsible for approximately 
218,000 working years lost between 2003 
and 2030, more than three times the number 
of working years lost due to female deaths 
(Figure 1). The 45 to 54 years age bracket 
accounted for the greatest number of 
working years lost for both men and women.
The PVLI lost due to premature deaths in 2003 
was estimated to be $13.8 billion between 
2003 and 2030, with a 95% confidence 
interval of $13.7 billion to $13.9 billion (Table 
2). Male deaths accounted for 81% of the 
total PVLI lost, which was a function of the 
higher number of premature deaths among 
men (15,836 more men than women died 
prematurely in the year 2003), their higher 
labour force participation (Figure 1) and 
their higher average incomes.32 Male deaths 
between the ages of 25 and 54 accounted for 
more than half the total PVLI impact. 
The PVLI lost due to premature mortality 
by cause of death was estimated (Table 3). 
Cancer was responsible for the greatest loss 
in PVLI (30%), followed by cardiovascular 
disease (19%), deaths from unintentional 
injuries (predominately transport accidents 
and falls) (15%) and deaths from intentional 
injuries (predominately suicide, self-harm and 
assault) (13%). 
The most costly cause of death, per death, 
was intentional injuries, representing an 
average PVLI loss of $765,000 per death. 
This was followed by mental disorders 
($654,000 per death) and unintentional 
injuries ($595,000 per death). The majority 
of premature deaths classified as having an 
underlying cause of mental disorder related 
to drug and alcohol dependence, but also 
included schizophrenia, anxiety, depression, 
bipolar disorder, personality disorders and 
eating disorders.
The diseases associated with the highest 
total PVLI loss for both men and women 
were assessed across 10 year age categories 
(Figure 2). For men aged 15–34, unintentional 
injuries resulted in the greatest total PVLI 
lost ($781 million), followed by intentional 
Table 1: Number of deaths and YLL in the 2003 mortality cohort*.
Male Female Total
Age Deaths in 2003 YLL to 2030 95% CI Deaths in 2003 YLL to 2030 95% CI Deaths in 2003 YLL to 2030 95% CI
<15  921  21,497 21,075–22,027  718  9,006 8,552–9,567  1,639  30,503 29,906–31,182
15-24  997  23,597 23,179–24,100  348  8,075 7,811–8,361  1,345  31,673 31,167–32,158
25-34  1,412  32,623 31,843–33,116  564  13,147 12,756–13,431  1,976  45,771 44,908–46,376
35-44  2,175  50,313 49,653–51,132  1,199  27,830 27,316–28,406  3,374  78,143 77,283–79,013
45-54  3,896  90,594 89,468–91,406  2,371  56,440 55,636–57,428  6,267 147,034 145,538–148,147
55-64  7,445 163,034 161,648–164,340  4,345  101,780 100,960–102,671  11,790  264,814 263,127–266,356
64-80  24,779  357,102 354,498–359,488  16,244  272,558 270,250–274,770  41,023  629,661 626,542–633,071
Total  41,625  738,760 735,879–742,280  25,789  488,838 486,521–491,366  67,414  1,227,598 1,223,312–1,232,069
YLL = years of life lost; CI = confidence interval.
* Numbers of deaths vary slightly from Carter et al (1) due to the effects of rounding at a higher level of disaggregation. 
Figure 1: Working years forgone due to premature mortality in 2003.
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the total PVLI lost. This reflected the relatively 
large number of deaths from these diseases 
as a proportion of total deaths (66%). 
In addition to considering the total PVLI lost, 
we reported the average PVLI lost per death 
by cause of death. Deaths from injuries, 
both unintentional and intentional, and 
mental disorders were the most costly in this 
regard, each accounting for a loss of more 
than $595,000 per death. This is reflected in 
our analysis of the costs of disease by age 
category and sex which revealed that injuries 
accounted for the greatest PVLI loss in men 
aged 15–34, a group which have the largest 
potential earning capacity to lose. 
It should be noted that we have based our 
estimates on the human capital approach, 
which is heavily influenced by the earnings 
potential of individuals. This method 
therefore gives greater weight to conditions 
affecting working age men compared 
with women, the young, the elderly, the 
indigenous and other ethnic minority 
groups. This approach is consistent with 
that adopted by most recent studies in this 
field,4,5,8,9,33 but is an important consideration 
when interpreting our results. We have also 
excluded the value of care giving, household 
work and earnings from the informal 
economy in our analysis. 
Our reference to ‘productivity’ costs 
throughout this manuscript has been 
adopted to reflect the common use of the 
term in the literature. However, we suggest 
that ‘production’ costs may be the more 
precise term for the types of losses we 
describe. By definition, production is the 
process of combining inputs to produce 
output, while productivity is a measure of the 
efficiency of each input in producing output. 
It is therefore conceivable that premature 
mortality could lead to a scenario where 
overall production goes down (because 
fewer people are working) but productivity 
(the average amount produced per person) 
remains the same, or even improves.
There are relatively few studies evaluating the 
productivity impacts of premature mortality 
available for comparative purposes. The 
‘Economic Burden of Illness In Canada 2005-
2008’ (EBIC) report15 provided estimates of 
the value of lost production due to premature 
mortality by age, sex and cause of death. 
While previous EBIC reports have applied 
the human capital approach to measure the 
value of lost production, the most recent 
report applied the friction method.16 Rather 
than measuring the present value of an 
Table 2: PVLI lost due to premature mortality in 
2003, by age and sex.
PVLI  
($ millions) 
95% CI % of 
total
Male
<15
15-24
25-34
35-44
45-54
55-64
64-80
Total
 163 
 797 
 1,655 
 2,582 
 3,110 
 2,013 
 884 
 11,204 
 153–171 
 774–821 
 1,607–1,697 
 2,544–2,625 
 3,063–3,164 
 1,975–2,045 
 858–914 
 11,129–11,307 
1%
6%
12%
19%
23%
15%
6%
81%
Female
<15
15-24
25-34
35-44
45-54
55-64
64-80
Total
 312 
 183 
 293 
 543 
 677 
 459 
 153 
 2,618 
 299–329 
 169–195 
 279–307 
 523–563 
 655–699 
 442–480 
 143–164 
 2,567–2,667 
2%
1%
2%
4%
5%
3%
1%
19%
All  13,821  13,740–13,945 100%
PVLI = Present value of lifetime income
injuries ($700 million). Cancer was the most 
common and costly cause of death for men 
aged 35–80 ($2.9 billion). The PVLI associated 
with premature mortality from cardiovascular 
disease became more significant in men 
aged 45 and above. Diseases of the digestive 
system were the fifth most costly category 
overall. 
In women, the PVLI lost due to cancer 
dominated the cost of all other causes of 
death in those aged 25–80 ($1.0 billion). The 
next most costly categories in terms of PVLI 
were cardiovascular disease, unintentional 
injuries, intentional injuries and nervous 
system and sense organ disorders.
A sensitivity analysis was performed whereby 
the younger age cut-off of 75 years was used 
to classify deaths as premature. This resulted 
in the exclusion of 4,932 deaths relative 
to our main analysis. The impact on total 
productivity costs was insignificant, with 0.2% 
fewer working years lost and a decrease of 
0.1% in the total PVLI loss reported. 
Discussion
This is the first study to provide estimates 
of the productivity impacts of all-cause 
premature mortality in Australia. When 
projected to 2030, premature deaths 
occurring in 2003 accounted for a total of 
295,000 working years lost and over $13.8 
billion in PVLI lost. Deaths from cancer and 
cardiovascular diseases were the most costly 
overall, together accounting for almost half 
Table 3: PVLI lost due to premature mortality in 2003, by cause of death
Cause of death Working 
years 
lost
PVLI lost ($ 
millions)
95% CI % of total 
PVLI
No. of 
deaths
PVLI per 
death  
($ millions)
Cancer 87,653 4,200 4,140–4,258 30% 25,733 0.163
Cardiovascular disease 51,659 2,582 2,541–2,633 19% 18,450 0.140
Unintentional injuries 40,942 2,017 1,968–2,058 15% 3,387 0.595
Intentional injuries 35,056 1,815 1,780–1,846 13% 2,371 0.765
Diseases of the digestive system 11,633 588 567–608 4.3% 2,466 0.238
Nervous system and sense organ disorders 9,206 439 419–460 3.2% 2,343 0.187
Chronic respiratory disease 8,110 377 359–395 2.7% 4,273 0.088
Mental disorders 7,280 376 358–393 2.7% 575 0.654
Congenital anomalies 5,160 201 189–212 1.5% 570 0.352
Infectious and parasitic diseases 5,064 261 248–274 1.9% 695 0.375
Neonatal causes 4,972 150 142–161 1.1% 600 0.250
Endocrine and metabolic disorders 4,369 209 193–223 1.5% 899 0.232
Diabetes mellitus 4,221 205 191–217 1.5% 1,732 0.118
Genitourinary diseases 2,936 141 131–151 1.0% 1,387 0.102
Acute respiratory infections 2,515 121 112–131 0.9% 932 0.130
Other neoplasms 1,363 63 55–70 0.5% 417 0.151
Musculoskeletal diseases 1,000 45 40–51 0.3% 383 0.118
Ill-defined conditions 626 19 16–22 0.1% 77 0.247
Skin diseases 178 8 6–11 0.1% 97 0.086
Maternal conditions 101 4 3–6 <0.1% 8 0.499
Nutritional deficiencies 18 1 0–1 <0.1% 16 0.042
Oral conditions 10 0 0–1 <0.1% 3 0.138
All 284,072 13,821 13,740–13,945 100% 67,414 0.205
PVLI = present value of lifetime income; CI = confidence interval
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individual’s future lifetime earnings, this 
method estimated the loss in production 
only for the period it takes to replace the 
deceased worker, referred to as the ‘friction 
period’. This method was chosen to reflect 
the current state of the Canadian labour 
market, specifically the high unemployment 
rates recorded in recent years. The study 
reported a total mortality-related cost of $464 
million (2010 Canadian dollars), significantly 
less than the LifeLossMOD estimate of 
$13.8 billion. This is unsurprising given the 
differences in methodology. However, the 
distribution of costs across age, sex and 
cause of death categories were closely 
aligned, with both LifeLossMOD and EBIC 
reporting the highest mortality related costs 
for males and individuals aged 35 to 54. In 
addition, both studies identified deaths from 
cancer, cardiovascular disease and injuries 
as accounting for the first, second and third 
highest productivity impact, respectively.
Menzin et al.33 developed a model using 
the human capital approach to estimate 
the productivity costs associated with all 
premature mortality across 29 selected 
countries, both developed and emerging. 
The model estimated the value of lost 
productivity by applying the present value 
of lifetime earnings (PVLE) to each death, 
stratified by country, age and sex. As in our 
results, the PVLE estimates were higher 
for certain subgroups, including men and 
younger working-age people. The average 
PVLE lost per death among males aged 18-34 
was estimated at £590,213 in the UK and 
$757,640 in the US (in their respective 2009 
currencies). Given the currency differences, 
these estimates are comparable to our finding 
of $1.0 million in the PVLI lost for all-cause 
male deaths aged 15-34.
Other recent studies have evaluated the 
economic impacts of premature mortality 
on disease specific subgroups, in particular 
cancer. Hanley et al.5 estimated that the 
Figure 2A: Diseases associated 
with the highest PVLI due to 
premature mortality in 2003, men.
Figure 2B: Diseases associated 
with the highest PVLI due to 
premature mortality in 2003, 
women.
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total cost of cancer-related premature 
mortality in Europe in 2008 was €75 billion, 
equating to an average cost per premature 
cancer-related death of €219,241. Similarly, 
Bradley et al.4 estimated the PVLE for cancer 
deaths in the US, and reported an average 
cost of $216,701 per cancer death in 2008. 
LifeLossMOD produced a comparable but 
slightly lower average PVLI per premature 
cancer related death of approximately 
$163,000. The difference may be explained in 
part by the truncation of our analysis at 2030, 
regardless of an individual’s modelled age 
and the exclusion of unpaid labour (including 
informal care and household work).
A 2006 study estimated the economic burden 
of cardiovascular disease across the European 
Union.11 CVD accounted for two million 
deaths in the EU, which translated to 2.18 
million working-years lost. The estimated cost 
of CVD deaths was €24.4 billion, equivalent to 
around €12,200 per death. This is significantly 
lower than our estimate of $140,000 in 
lost PVLI per death, and may be explained 
by the truncation of the EU analysis at the 
traditional retirement age. LifeLossMOD 
allows individuals to continue earning income 
beyond the traditional retirement age, and 
accounts for the projected increase in the 
age at which people will retire in the future. 
The higher LifeLossMOD figure may also be 
explained by the broader scope of the PVLI 
estimate and its inclusion of income sources 
outside of wages.
The relatively large variation in the estimates 
of the economic burden of mortality across 
different studies and countries demonstrates 
how geographical differences in the pattern 
of deaths and labour force dynamics may 
influence the nature and size of the estimates 
produced. This appears to be further 
compounded by differences in the type of 
data used and the methodological approach 
taken. A key advance of our study is the 
use of a single, complete mortality dataset 
and a consistent methodology to generate 
results across deaths from all causes while 
maintaining the capacity to report on impacts 
by cause of death. This allows for highly 
reliable order of magnitude comparisons 
of the impacts of mortality across various 
disease groups. Because each death in our 
mortality dataset was assigned only to the 
primary cause of death, we have avoided 
overstating the impacts by ‘double-counting’ 
a death in more than one disease category. 
Our results further extend on the previous 
research by applying a microsimulation 
modelling technique that is able to account 
for significantly greater variation and 
complexity in generating projections. This 
approach builds on recent microsimulation 
methods developed by Schofield et al. that 
were applied to determine the economic 
impacts of illness in older Australians,34 and 
has several advantages. A key strength of 
this approach was its ability to impute key 
variables of interest onto individual level 
mortality records, using reliable data sources 
and statistically robust techniques. It was 
therefore possible to significantly enrich the 
data available for analysis. The advantage 
of this approach over the use of aggregate 
datasets is that, because individual-level data 
is being used, the variation and complexity in 
the analysis could be significantly increased. 
It was therefore possible to account for 
differences in income across individual 
combinations of age, sex and socio-economic 
status. In addition, the estimates are able to 
account for projected trends in wage growth, 
labour force participation and retirement 
age. A further significant advantage of the 
microsimulation approach is its capacity to 
account for a broader scope of impacts than 
lost wages alone, including the impacts on 
labour force participation and total income 
which includes income generated from 
business profits and investments. 
The model is limited by the predictive ability 
of the covariates used to link the mortality 
records with similar individuals in the APPSIM 
microsimulation model, those being age, sex 
and SEIFA index. We attempted to address 
this uncertainty by bootstrapping the process 
used to assign these counterfactuals to create 
100 unique simulations. The results presented 
here report the mean of the 100 simulations 
along with confidence intervals generated 
by the bootstrapping process. The relative 
narrowness of the confidence intervals 
indicate that our results are robust to the 
effects of uncertainty in the record matching 
process. 
Our analysis of productivity impacts was 
based on the officially registered underlying 
cause of death. This is defined in accordance 
with the International Classification of 
Diseases as the disease or injury which 
initiated the train of morbid events leading 
directly to death, or the circumstances of 
the accident or violence which produced 
the fatal injury.35 While this approach was 
necessary to avoid the double-counting 
of productivity impacts at an all-cause 
mortality level, the contribution of certain 
diseases to overall productivity costs may be 
underestimated. This is most likely evident 
for common comorbidities including chronic 
and unspecified kidney failure, diabetes, 
asthma, COPD, and dementia and Alzheimer 
disease. In interpreting our results, attention 
must be given to the broader cause of 
death categories we have applied; these are 
detailed in the Burden of Disease and Injury in 
Australia 2003 study.21 
Australia, like most developed economies, 
has an ageing population. As more people 
move into older age groups, overall workforce 
participation rates are projected to drop from 
around 63.5% in 2003-04 to 56.3% by 2044-
45, and hours worked per capita will be about 
10% lower than without ageing.18 In this 
context, maximising workforce participation 
is increasingly being recognised as a key 
policy focus required to sustain economic 
growth. This paper highlights the significant 
labour force impacts associated with 
premature mortality, and thus the potential 
for investment in interventions that prevent 
mortality to have positive impacts on the size 
of the workforce. 
There is a wealth of existing literature 
assessing the cost effectiveness of health care 
interventions and highlighting interventions 
which provide good value for money. For 
example, the 2013 World Health Organisation 
Global Action Plan for the Prevention and 
Control of Noncommunicable Diseases36 
identified a number of interventions that 
are affordable and give a good return on 
investment, generating one year of healthy 
life for a cost that falls below the gross 
domestic product (GDP) per person. Similarly, 
the recent ACE-Prevention study assessed the 
relative cost-effectiveness of a comprehensive 
set of preventive interventions for non-
communicable disease in Australia, together 
with a selected set of comparator care/cure 
intervention.37 The study then recommended 
a ’menu’ of cost effective interventions 
from which policy makers can select within 
available budgets. However, previous studies 
such as these have typically taken a health 
care perspective, with outcomes valued in 
terms of the likely health benefits gained 
but overlooking the potential economic 
benefits that would also arise. Our results 
provide decision makers with valuable 
information on the nature and scope of this 
additional set of productivity benefits. When 
interpreted alongside information on the cost 
effectiveness of health care interventions, this 
allows for an alternative, but complementary 
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perspective on the long-term returns of 
health care investment which may be used to 
inform priority setting. 
Conclusions
The cost of premature mortality to the 
Australian economy is substantial, with 
the long-term impacts of deaths in 2003 
accounting for over 284,000 full time 
equivalent working years lost, and $13.8 
billion in the PVLI lost, to 2030. The results 
from this study provide an assessment of the 
relative productivity impacts associated with 
premature mortality across the major cause of 
death categories, as well as a comprehensive 
overview of the distribution of these impacts 
by age and sex. This information can be 
used by decision makers in allocating scarce 
resources between competing priorities 
and may provide valuable information to 
governments seeking to improve not only the 
health but also the productivity of a nation.
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